Rxcurve
HCPCS J1410 · per 25 MG

Inj estrogen conjugate 25 mg

Products billed under this code include Premarin.

Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1410

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Premarin Pfizer Inc 00046-0749-05 1 $402.131

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $402.131 +$0.628 25 MG Inj estrogen conjugate 25 mg v1, posted September 17, 2026
3Q26 $401.503 +$9.785 25 MG Inj estrogen conjugate 25 mg v1, posted September 15, 2026
2Q26 $391.718 −$0.043 25 MG Inj estrogen conjugate 25 mg v1, posted September 15, 2026
1Q26 $391.761 −$0.302 25 MG Inj estrogen conjugate 25 mg v1, posted September 15, 2026
4Q25 $392.063 +$1.32 25 MG Inj estrogen conjugate 25 mg v1, posted September 8, 2026
3Q25 $390.743 +$7.856 25 MG Inj estrogen conjugate 25 mg v1, posted March 10, 2026
2Q25 $382.887 −$0.025 25 MG Inj estrogen conjugate 25 mg v1, posted March 10, 2026
1Q25 $382.912 +$0.126 25 MG Inj estrogen conjugate 25 mg v1, posted December 19, 2025
4Q24 $382.786 −$1.244 25 MG Inj estrogen conjugate 25 mg v1, posted June 11, 2025
3Q24 $384.03 +$11.663 25 MG Inj estrogen conjugate 25 mg v1, posted June 11, 2025
2Q24 $372.367 +$0.221 25 MG Inj estrogen conjugate 25 mg v1, posted March 11, 2025
1Q24 $372.146 −$0.33 25 MG Inj estrogen conjugate 25 mg v1, posted December 19, 2024
4Q23 $372.476 +$0.583 25 MG Inj estrogen conjugate 25 mg v1, posted October 10, 2024
3Q23 $371.893 +$16.112 25 MG Inj estrogen conjugate 25 mg v1, posted June 5, 2024
2Q23 $355.781 +$0.258 25 MG Inj estrogen conjugate 25 mg v1, posted February 23, 2024
1Q23 $355.523 +$0.032 25 MG Inj estrogen conjugate 25 mg v1, posted December 6, 2023
4Q22 $355.491 +$1.821 25 MG Inj estrogen conjugate 25 mg v1, posted June 22, 2023
3Q22 $353.67 +$12.178 25 MG Inj estrogen conjugate 25 mg v1, posted June 9, 2023
2Q22 $341.492 −$0.009 25 MG Inj estrogen conjugate 25 mg v1, posted December 14, 2022
1Q22 $341.501 +$0.045 25 MG Inj estrogen conjugate 25 mg v1, posted June 8, 2022
4Q21 $341.456 −$0.309 25 MG Inj estrogen conjugate 25 mg v1, posted June 2, 2022
3Q21 $341.765 +$16.306 25 MG Inj estrogen conjugate 25 mg v1, posted June 2, 2022
2Q21 $325.459 −$0.048 25 MG Inj estrogen conjugate 25 mg v1, posted March 1, 2022
1Q21 $325.507 – 25 MG Inj estrogen conjugate 25 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files